Role for HPV testing in ASCUS: A cytologic-histologic correlation

Diagnostic Cytopathology

Volumn 27, Issue 6, 2002, Pages 382-386

  Crabtree, Dwayne ^a,d   Unkraut, April ^b   Cozens, Donna ^b   Smith, Tina ^b   Lucas, Cinda ^b   Pennington, Donna ^b   Chaney, Lois ^b   Nestok, Blake ^c   Robinson Smith, Toni ^a   Yassin, Rawia ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Hlth Alliance of Greater Cincinnati   (United States)

^c CHRIST HOSPITAL   (United States)

^d C/O Cincinnati COM Path Dept ^*  (United States)

Author keywords

ASCUS; Human papillomavirus typing; Hybrid capture methodology; ThinPrep PapTest

Indexed keywords

ADULT; ARTICLE; ATYPICAL SQUAMOUS CELL OF UNDETERMINED SIGNIFICANCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PAPANICOLAOU TEST; PATHOLOGY; PRIORITY JOURNAL; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; UTERINE CERVICITIS; WART VIRUS; ADOLESCENT; CLASSIFICATION; FEMALE; FOLLOW UP; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PAPILLOMA VIRUS; SINGLE BLIND PROCEDURE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

VIRUS DNA;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SINGLE-BLIND METHOD; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0036894652     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.10198     Document Type: Article

References (12)

1. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299.
2. Wright TC. Is there a role for HPV DNA testing in routine practice? OBG Manage 2001;March:1-8.
3. Thin Prep 2000 system operator's manual. Boxborough, MA: Cytyc Corp.
4. Kurman RJ, Solomon D. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. New York: Springer; 1994.
5. HPV DNA Test Hybrid Capture® II: Package Insert. Gaithersburg, MD: Digene Corp.
6. Manos MM, Kinney WK, Hurley LB. et al. Identifying women with cervical neoplasia: Using human papilloma virus testing for equivocal Papanicolaou results. JAMA 1999;281:1605-1610.
7. Gatscha RM, Abadi M, Babore S, Chieng D, Miller MJ, Saigo PE. Smears diagnosed as ASCUS: Interobserver variation and follow-up. Diagn Cytopathol 2001;25:138-40.
8. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System. JAMA 2002;287:2114-2119.
9. Clavel C, Masure M, Bory J-P, et al. Hybrid Capture® II-based human papilloma virus detection, a sensitive test to detect routine high grade cervical lesions: A preliminary study on 1518 women. Br J Cancer 1999;80:1306-1311.
10. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus guidelines for cervical cytological abnormalities. JAMA 2002;287:2120-2129.
11. Davis GL, Hernandez JL, Davis JL, Miayazawa K. Atypical squamous cells of undetermined significance: A cytohistologic study of 52 cases. Acta Cytol 1997;41:1671-1675.
12. Sandmire HF, Austin SD, Bechtel RC. Experience with 40,000 Papanicolaou smears. Am J Obstet Gynecol 1976;48:56-60.